China Huajun GP (ASX: 00377) has announced that the share subscription agreement under its general mandate has lapsed.
The subscription was conditional upon fulfilling certain terms of the agreement by May 31, 2026.
As of the announcement date, not all conditions had been satisfied, leading to the agreement becoming void.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments